Citation: R. Kircheis et al., CYTOKINE GENE-MODIFIED TUMOR-CELLS FOR PROPHYLACTIC AND THERAPEUTIC VACCINATION - IL-2, IFN-GAMMA, OR COMBINATION IL-2-GAMMA(IFN), Cytokines cellular & molecular therapy, 4(2), 1998, pp. 95-103
Authors:
KOPPENHAGEN FJ
KUPCU Z
WALLNER G
CROMMELIN DJA
WAGNER E
STORM G
KIRCHEIS R
Citation: Fj. Koppenhagen et al., SUSTAINED CYTOKINE DELIVERY FOR ANTICANCER VACCINATION - LIPOSOMES ASALTERNATIVE FOR GENE-TRANSFECTED TUMOR-CELLS, Clinical cancer research, 4(8), 1998, pp. 1881-1886
Authors:
OGRIS M
STEINLEIN P
KURSA M
MECHTLER K
KIRCHEIS R
WAGNER E
Citation: M. Ogris et al., THE SIZE OF DNA TRANSFERRIN-PEI COMPLEXES IS AN IMPORTANT FACTOR FOR GENE-EXPRESSION IN CULTURED-CELLS/, Gene therapy, 5(10), 1998, pp. 1425-1433
Authors:
FINKE S
TROJANECK B
LEFTEROVA P
CSIPAI M
WAGNER E
KIRCHEIS R
NEUBAUER A
HUHN D
WITTIG B
SCHMIDTWOLF IGH
Citation: S. Finke et al., INCREASE OF PROLIFERATION RATE AND ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF EXPANDED HUMAN CD3(-CELLS BY RECEPTOR-MEDIATED TRANSFECTION WITH THE INTERLEUKIN-7 GENE()CD56(+) IMMUNOLOGICAL EFFECTOR), Gene therapy, 5(1), 1998, pp. 31-39
Authors:
BUCHBERGER M
KIRCHEIS R
WAGNER E
GADNER H
FELZMANN T
Citation: M. Buchberger et al., EX-VIVO GENE-TRANSFER INTO NEUROBLASTOMA-CELLS FOR THE DEVELOPMENT OFTUMOR VACCINATION STRATEGIES, Cancer gene therapy, 3(6), 1996, pp. 26-26
Authors:
FINKE S
TROJANECK B
LEFTEROVA P
CSIPAI M
KRUOPIS S
WAGNER E
KIRCHEIS R
NEUBAUER A
HUHN D
WITTIG B
SCHMIDTWOLF IGH
Citation: S. Finke et al., ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF HUMAN IMMUNOLOGICAL EFFECTOR-CELLS BY TRANSFECTION WITH THE INTERLEUKIN-7 GENE, Blood, 88(10), 1996, pp. 3889-3889